SIRTP :: Welcome
Chairman's Message

Er. Sanjeev Agrawal
My colleagues and I are striving to transform SGI into a Knowledge Enterprise. The relevant concepts that we expect to build into SGI are: A knowledge enterprise is an enterprise, which is capable of production, marketing, maintenance and innovation of knowledge as a product. This will consist of collection of data, conversion into information and learning to use and apply the knowledge for specific and useful purposes. This can be done through using Information Technology as a tool, through which the transfer of knowledge and the capability to use it will be done to the needy normally at a price.
Read More

To Motivate and Mould students in to world class Pharma Professionals who will excel in their fields and effectively meet the challenges of the dynamic global scenario.


Working towards being the best ---

M1: To produce technically proficient and motivated Pharmacy graduates and entrepreneurs through IT based knowledge management in Pharmaceutical education to meet global challenges.
M2: To instill ethical, moral, cultural and professional values in graduates.
M3: To provide state of art infrastructure facilities and latest technological advancements to students.

News & Events

»Janamashthami celebration at SIRTP was conducted on 1st Sept, 2018.
»Glass Painting workshop was conducted on 14th July 2018 at Sagar Institute of Research and Technology-pharmacy.
»Sagar Institute of Research and Technology-Pharmacy has organised "BHOPAL BHRAMAN" trip for B.Pharm first year students on 6 Aug 2018.
»Oreintation Programme for B.Parm I semester, Batch 2018 was conducted successfully on 6 August 2018.
»7th Semester visited Vindhya Herbals Company under VAC on 3 July, 2018.
»A Campus Drive was conducted At SIRT Pharmacy on 12 June 2018.
»Value Addition Course for 7th semester was conducted from 1/6/18 to 20/6/18.
»Value Addition Course was conducted on 4th & 5th May 2018 for B.Pharm Final year students at SIRTP.
»Freshers and Farewell was organized In SIRT-P on 28, April 2018.
»National Seminar was celebrated in SIRT-P College.
»A Tremendous Performance by student of SIRT-P in GPAT 2018.
»An Immense performance of SIRT-P in MP- Pride 2018 National Conference
»A Student of SIRT-P awarded Chancellor Scholarship Prize.
»SIRT Pharmacy participated in RUN BHOPAL RUN on 3 Dec,2017.
»56th National Pharmacy week was organized in association with SAC On 18/11/2017 in SIRT-P.
»Greeting Card making competition was organized under SAC On 11/10/2017 in SIRT-P.The theme of this Competition was on Diwali.
»SIRTP organised Talkathon "a step towards speaking is a run towards talking" on Tuesday , October 10th.
»Oreintation Programme for B.Parm I semester, Batch 2017 was conducted successfully on 10 August 2017.
»Two days VAC programme for V sem students on "LOCOMOTOR ACTIVITY OF RATS ON ROTAROD AND ACTOPHOTOMETER" was organized.
»A 21 Days , Value addition course titled Hands on training cum workshop (Pharmaceutics-Pharmacology-Pharmaceutical analysis), VAC Programme for VII sem students were organized during 28th June to 22nd July 2017. 36 Students were participated in this training.
»Two days VAC programme for III sem students on "Isolation of Phyto constitutes by Chromatography technique" were organized on 24th and 25th July 2017.
»Two days VAC programme for V sem students on Animal handling and drug screening will be held on 18th and 19th Aug 2017.
» B.Pharmacy Course Accreditation by National Board of Accreditation
» A MoU has been signed between SIRT-Pharmacy & Rapture Biotech, Noida in presence of Dr. Mayank Raj Bharadwaj, CEO, Rapture Biotech, Noida, Dr. Surendra Jain, all staff & students on 09th March 2016.
» VAC was conducted on the topic entitled "Workshop on UPLC" (B. Pharm. VI semester) 5 thJan. & 6 th Jan. 2016
» VAC was conducted on the topic entitled "Personality development and facing interview" (B. Pharm. VIII semester) 18 thJan. & 19 th Jan. 2016.
» VAC was conducted on the topic entitled "Dissolution testing protocol for solid dosage form” (B. Pharm. IV semester) 1st Feb & 2ndFeb 2016
» VAC was conducted on the topic entitled "Extraction techniques of herbal drugs” (B. Pharm. II semester) 29 thFeb. & 01 stFeb. 2016.
» Guest lecture and MOU signed by Dr.Amit Nayak, Director, Phyto Drug Pvt. Ltd., Sagar, M.P.with Sagar Institute of Research and Technology Pharmacy, representative Dr. Prashant Jain (E.D. SGI), Dr. Surendra Kumar Jain, Director, SIRT-P.
» B. Pharm. and M. Pharm. admission (Registration start) For more information: Visit SIRT-P campus
» VAC was conducted on the topic entitled “Communication Skill and Personality Grooming” (B. Pharm. II semester) 4th June & 5th June 2015.
» VAC was conducted on the topic entitled “Animal Handling and Pharmacological Experimental Techniques” (B. Pharm. IV semester) 2nd June & 3rd June 2015.
» Three weeks In House “Industrial Training Cum Workshop” for our students of prefinal year was conducted under the banner of SIFC in between 06-21 June 2015.
» A guest Lecture by Mr. Prabhat Jain on “HPLC working and Application”.
» A guest Lecture by Mr. Sarvesh Sharma on “FTIR working and Application”.
» A guest Lecture by Mr. Nitesh Jain on “HVAC System and Industrial Setup”.
» An open campus interview of Labcorp India Pvt. Ltd. has been conducted for B. Pharm. final year and pass out students. More than 70 Students participated in the campus drive from all around institutes. 12 students were shortlisted for second round, 05 from SIRTP.
» A new Instrument “UPLC” Installed at SIFC lab by Hon. Chairman Sir “Er. Sanjeev Agrawal” under the scheme of RPS of AICTE Sanctioned to Dr. Surendra Kumar Jain.
» Industrial training cum workshop for B. Pharm. VI sem students is organize at SIRT-P campus under SIFC Lab centre. Registration Last date: 15 May 2015.
» UPLC (Ultra performance liquid chromatography) facility for research purpose is now available at SIRT-P campus under SIFC Lab centre.

at SIRTP campus.

» Sophisticated Instrument Facility Centre is established at SIRTP campus for pursuing research projects via post graduates and Ph. D. students.
» Pharma industry executive will visit our institute in next month for placement in the production for B. Pharm and M. Pharm students.
» Freshers & Farewell Party for the batch of 2015 is organised on 2nd May 2015 at SIRT-P Campus
» Guest lecture and MOU signed by Dr. Anuvrat Sharma, M.D., Viola Life Sciences, Ahmedabad, Gujrat with Sagar Institute of Research and Technology – Pharmacy, representative Dr. Prashant Jain (E.D. SGI), Dr. Surendra Kumar Jain, Director, SIRT-P.
» Four Day International Conference on Interdisciplinary Research in Engineering, Management, Pharmacy and Sciences (ICIREMPS) - 2015 successfully completed on Feb, 2015. Various researchers, industrialists & scholars presented their research papers in various sessions. Various experts from different fields delivered lectures and enlighted with their knowledge
» The research projects of M. Pharm & Ph.D. animals were approved as per research project requirement under the CPCSE norms. The suggestions and decisions were made by committee members.
» In continuation the SIRT-P conduct a number of events and all students along with faculty member participated very joyfully in all the programs, especially in blood donation & Eye donation pledge, which were organized with the help of Hamidiya Hospital Bhopal.
» Memorandum of Understanding (MOU) was signed between Sagar Institute of Research & Technology Pharmacy representative Director, Dr. S. K. Jain and Lapiz Pharmaceutical Pvt. Ltd., Sagar representative Mr. Jaiwant Thakur in presence of SGI group chairman Er. Sanjeev Agrawal, ED. Dr Prashant Jain, OSD Prof. P.S. Rajput and SIRTP.
» Memorandum of Understanding (MOU) was signed between Sagar Institute of Research & Technology Pharmacy representative SGI group ED, Dr. Prashant Jain and ONIOSOME Pvt. Ltd., Chandigarh representative Dr. Sarvesh Jain in presence of SGI group chairman Er. Sanjeev Agrawal, OSD Prof. P.S. Rajput and SIRTP Director Dr. Surendra K Jain.
» Memorandum of Understanding (MOU) was signed between Sagar Institute of Research & Technology Pharmacy representative SGI group ED, Dr. Prashant Jain and PBRI, Bhopal representative Dr. Ezaz Khan in presence of SGI group chairman Er. Sanjeev Agrawal, OSD Prof. P.S. Rajput and SIRTP Director Dr. Surendra K Jain.
» Students of SIRTP visited Vindhya Herbal industrial visit scheme of the institution. students were briefed by the director of Vindhya Herbal himself about the production unit, training section and nursery of the herbal industry. Vndhya Herbal is state's only producer of ayurvedic products. On this occassion ED Dr. Prashant Jain and Chairman Er. Sanjeev Agrawal congratulated the students and also appreciate to the Director of SIRTP Dr. Surendra K Jain for arrange such kind of programme.

(201) 947-0562

Conferences & Pharma Sector News

JULY 16, 2018. Officials with the FDA have approved tecovirimat (TPOXX, SIGA), the first drug with an indication for the treatment of smallpox, to boost preparedness in the event of a bioterror attack, according to a press release.
MARCH 30, 2018. FDA Expands Indication of ALL Treatment for Patients with Increased Relapse Risk. Officials with the FDA have expanded the approval of blinatumomab (Blincyto, Amgen) to include the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal residual disease (MRD), according to a press release. This is the first FDA-approved treatment for patients with MRD-positive ALL. Blinatumomab was first approved by the FDA under accelerated approval in December 2014 for the treatment of Philadelphia chromosome (Ph)-negative relapsed or refractory positive B-cell precursor ALL. Full approval was granted in July 2017, when the indication was also expanded to include patients with Philadelphia chrosome- positive ALL.
MARCH 20, 2018. Officials with the FDA have expanded the approval of brentuximab vedotin (Adcetris) to include treatment-naïve adults with stage 3 or 4 classical Hodgkin lymphoma (cHL),in combination with chemotherapy. Brentuximab vedotin combines an antibody and a drug that targets CD30 on lymphoma cells. The FDA previously authorized brentuximab vedotin to treat cHL after relapse and after stem cell transplant in high-risk patients. Additionally, the drug is approved to treat systemic anaplastic large cell lymphoma (ALCL) after treatment failure and primary cutaneous ALCL after treatment failure.
MARCH 13, 2018. FDA Approves Smart Continuous Glucose Monitoring System (Guardian Connect) for use by individuals living with diabetes, according to a company press release. The Guardian Connect System is indicated for patients aged 14 to 75 years old with diabetes. patients of potential high or low glucose events up to 60 minutes in advance. The approval is based on a clinical study that demonstrated the system’s ability to accurately alert patients of 98.5% of hypoglycemic events while using Medtronic’s advanced glucose sensor, Guardian Sensor 3. The Guardian Connect system gives caregivers the opportunity to track glucose in real time or receive text alerts. Additionally, the system offers access to the Sugar.IQ smart diabetes assistant, an artificial technology product from IBM Watson Health, which continually analyzes how an individual’s glucose levels respond to their food intake, insulin dosages, daily routines, and other factors. The Guardian Connect System will be available in the first quarter of Medtronic’s fiscal year 2019 (May 2018-July 2018).
March 9, 2016 -- Today, the U.S. Food and Drug Administration approved the first generic version of Viagra (sildenafil citrate), for the treatment of erectile dysfunction. Teva Pharmaceutical Industries received approval to market generic sildenafil citrate tablets in 25 mg, 50 mg, and 100 mg strengths and has 180-day exclusivity. For information about the availability of these products, contact the manufacturer.
• Patients should talk to their doctor or pharmacist if they have heart problems, stroke in the past six months, kidney disease, liver disease, high or low blood pressure, a severe loss of body water, history of painful/prolonged erection, conditions that may increase the risk of painful/prolonged erection (such as sickle cell anemia, leukemia, multiple myeloma), and eye problems.
• Generic drugs approved by FDA have the same high-quality and strength as brand-name drugs. The generic manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

Pharma Jobs

• Required B.Pharm & B.E Instrumentation graduates for apprenticeship at Cadila Healthcare Limited, Moraiya plant, Ahmedabad
Eligibility Criteria: B.Pharm/ B.E. Instrumentation Freshers(2017/2018 pass out only) Email resume to:
• Vacancy in Karnataka Antibiotics and Pharmaceuticals KAPL Recruitment 2018

Management Trainee: B.pharm, M.Pharm, B.Sc, B.Tech/B.E, M.Sc
Job Location: Bengaluru/ Bangalore
Total Vacancies: 09
Date: 18/7/18
Last Date: 30/7/18

• Indian Pharmacopoeia Commission PCIM Recruitment 2018
Technical Assistant: B.Sc
Senior Research Fellow: M.Pharm, M.Sc, M.E/ M.Tech
Research Associate: M.Pharm, M.Phil/ P.hD, , M.E/ M.Tech ,M.Sc
Total Vacancy: 03
Location: Ghaziabad
Last Date: 26/7/18


Our Recruiters